Trials / Conditions / Androgenetic Alopecia

Androgenetic Alopecia

147 registered clinical trials studyying Androgenetic Alopecia — 24 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia. NCT07529977	Eurofarma Laboratorios S.A.	Phase 3
Not Yet Recruiting	XVIE to Treat Androgenetic Alopecia (AGA) NCT07482423	Restore Biologics Holdings, Inc. dba Xtressé	Phase 1 / Phase 2
Not Yet Recruiting	Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth NCT06648850	Applied Biology, Inc.	Phase 2 / Phase 3
Not Yet Recruiting	Harnessing Artificial Intelligence for Diagnosing Androgenetic Alopecia: A Training and Validation Study NCT07294313	Cairo University	—
Not Yet Recruiting	Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia NCT07490327	Moogene Medi Co., Ltd	Phase 1 / Phase 2
Not Yet Recruiting	The Effect of Nanofat Injection on Androgenetic Alopecia NCT07518342	Assiut University	Phase 4
Recruiting	Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients NCT07429253	PT. Prodia Stem Cell Indonesia	Phase 1 / Phase 2
Not Yet Recruiting	A Split-Scalp Study Evaluating the Efficacy and Safety of Fractional Laser Therapy With and Without Exosomes i NCT07248410	Chang Gung Memorial Hospital	N/A
Not Yet Recruiting	Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical NCT07112586	Ain Shams University	Phase 1 / Phase 2
Recruiting	Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA) NCT07146022	Veradermics, Inc.	Phase 3
Recruiting	Efficacy & Safety of Minoxidil SL Tablets in Men With AGA NCT06924632	Samson Clinical Operations Pty Ltd	Phase 3
Completed	Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss. NCT07433933	Lacer S.A.	—
Not Yet Recruiting	A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia NCT06916793	Chong Kun Dang Pharmaceutical	Phase 3
Completed	Evaluation of the Safety, Tolerability and Pharmacokinetics of AH-001 Following Topical Single and Multiple As NCT06927960	AnHorn Medicines Co. Ltd.	Phase 1
Active Not Recruiting	Safety and Efficacy of VDPHL01 in Males With AGA NCT06972264	Veradermics, Inc.	Phase 3
Recruiting	Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia NCT07080931	Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.	Phase 3
Not Yet Recruiting	Various Procedural Treatment Options for Androgenetic Alopecia NCT06826001	Sheikh Zayed Medical College	Phase 2
Not Yet Recruiting	Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss NCT06501924	Applied Biology, Inc.	Phase 3
Enrolling By Invitation	The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia. NCT06764329	National Institute of Blood and Marrow Transplant (NIBMT), Pakistan	Phase 1 / Phase 2
Active Not Recruiting	Efficacy and Safety of VDPHL01 in Males With AGA NCT06724614	Veradermics, Inc.	Phase 2 / Phase 3
Not Yet Recruiting	Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss NCT06590779	Cosmetique Active International	N/A
Recruiting	Six-Month Single-Blind, Placebo-Controlled Study of a Dietary Supplement Supplement on Hair Growth in 45 Volun NCT06841458	Industrial Farmacéutica Cantabria, S.A.	N/A
Withdrawn	Clinical Study of Probiotic Treatment for Androgenetic Alopecia NCT06484881	Applied Biology, Inc.	Phase 3
Not Yet Recruiting	Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia NCT05888922	Industrial Farmacéutica Cantabria, S.A.	Phase 3
Not Yet Recruiting	Efficacy of Stromal Vascular Fraction Versus Platelet Rich Plasma in Treatment of Androgenitic Alopecia NCT06558565	Kasr El Aini Hospital	N/A
Completed	Development and Standardization Methods NCT06802237	NovoBliss Research Pvt Ltd	—
Active Not Recruiting	Safety and Efficacy of VDPHL01 in Males and Females With AGA NCT06527365	Veradermics, Inc.	Phase 2
Not Yet Recruiting	Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic Alopecia NCT06482541	Levit Dermatology	Phase 1
Completed	Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA NCT06393452	Pelage Pharmaceuticals, Inc.	Phase 2
Completed	Exosome Treatment in Androgenetic Alopecia NCT06539273	Yeditepe University Hospital	Phase 3
Unknown	Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic NCT06218394	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Recruiting	1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia NCT05460611	Montefiore Medical Center	N/A
Unknown	Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment NCT06218498	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Completed	Evaluation of the Niostem Headset for Hair Growth and Hair Quality NCT06994819	Mane Biotech GmbH	N/A
Completed	Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia NCT06239207	Services Hospital, Lahore	Phase 2
Completed	A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia NCT06118866	Hope Medicine (Nanjing) Co., Ltd	Phase 2
Completed	Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss NCT06149221	Dr. Peter C. Friedman	N/A
Unknown	Hair Regeneration in Androgenetic Alopecia NCT06066827	Dr. dr. Lili Legiawati, SpKK(K)	N/A
Unknown	Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia NCT05864885	Aneira Pharma, Inc.	Phase 1
Unknown	Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alo NCT06043349	Indonesia University	Phase 4
Completed	Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss NCT05970809	StimuSIL	N/A
Completed	Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men NCT05989165	Indonesia University	Phase 3
Unknown	Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for Th NCT05990400	Indonesia University	Phase 2 / Phase 3
Recruiting	Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia NCT04594018	EMS	Phase 3
Completed	A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia NCT05677438	Chong Kun Dang Pharmaceutical	Phase 2
Completed	Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men NCT05636904	Dermaliq Therapeutics, Inc.	Phase 1 / Phase 2
Withdrawn	Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia NCT03852992	University of Minnesota	Phase 2
Active Not Recruiting	Use of Botulinum Toxin in the Treatment of Androgenic Alopecia NCT05456087	Zel Skin and Laser Specialists	Phase 2
Withdrawn	Thulium Laser and Topical Platelet Rich Plasma (PRP) vs. PRP Injection for the Treatment of Male Androgenetic NCT05129254	Montefiore Medical Center	N/A
Recruiting	Sham LaserCap vs. LaserCap SD vs. LaserCap HD+ NCT05365360	University of Arizona	N/A
Completed	Activated PRP for Treatment of Androgenetic Alopecia NCT05348343	Santiste Medical Inc.	Phase 1 / Phase 2
Completed	To Evaluate the Safety, Tolerability and Efficacy in Male and Female with AGA Treated with HMI-115 Over a 24-w NCT05324293	Hope Medicine (Nanjing) Co., Ltd	Phase 1
Completed	Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029 NCT05428449	Suzhou Kintor Pharmaceutical Inc,	Phase 1
Unknown	Phase III Study of KX-826 With Adult Male Patients With AGA NCT06126965	Suzhou Kintor Pharmaceutical Inc,	Phase 3
Completed	Combined Use of Povidone-Iodine and Rifampicin in Hair Transplantation NCT07155408	Elif Asena KANTARCI	N/A
Completed	A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001 NCT04945226	Inventage Lab., Inc.	Phase 1 / Phase 2
Withdrawn	Thulium Laser and KeraFactor for the Treatment of Androgenetic Alopecia NCT04882969	Montefiore Medical Center	N/A
Completed	A Study to Evaluate the Efficacy and Safety of AD-208 NCT04825561	Addpharma Inc.	Phase 3
Completed	Clinical Evaluation of Localized Scalp Thread Embedding for Male Androgenetic Alopecia NCT06879119	Beijing University of Chinese Medicine, Shenzhen Hospital	N/A
Unknown	Androgenetic Alopecia Treatment Using Varin and Cannabidiol Rich Topical Hemp Oil: A Case Series NCT04842383	Gregory L Smith, MD, MPH	EARLY_Phase 1
Completed	Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19). NCT04898166	Syeda Mahanum Ali	—
Completed	Anti-Androgen Treatment for COVID-19 NCT04446429	Applied Biology, Inc.	N/A
Unknown	Low Level Light Device as a Primary Therapy for Androgenetic Alopecia NCT04558242	Kiierr International, LLC	N/A
Completed	Topical Cetirizine in Androgenetic Alopecia in Females NCT04481412	Cairo University	Phase 2 / Phase 3
Completed	Cold Plasma to Treat Hair Loss NCT04379752	Dr. Peter C. Friedman	N/A
Completed	A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Ma NCT04774874	Follicum AB	Phase 2
Withdrawn	HairDx Analytical Validation Study NCT04379583	Applied Biology, Inc.	—
Unknown	Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia NCT04293822	Assiut University	Phase 4
Withdrawn	In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity NCT04368897	Applied Biology, Inc.	—
Completed	the Safety, Tolerability and PK of KX-826 in Healthy Males With Alopecia Following Topical Multiple Dose Ascen NCT04502901	Suzhou Kintor Pharmaceutical Inc,	Phase 1
Unknown	Efficacy of Platelet-Rich Plasma Therapy for Androgenetic Alopecia: A Systematic Review and Meta-analysis NCT04191005	Jasim Mohammed Alshammari	—
Completed	To Evaluate the Pharmacokinetics and Safety of AD-208 NCT04214808	Addpharma Inc.	Phase 1
Withdrawn	The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia NCT03048461	Northwestern University	Phase 2
Completed	Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Followi NCT04984707	Suzhou Kintor Pharmaceutical Inc,	Phase 1
Completed	N-Acetyl-Cysteine for Treatment of AGA in Men NCT04209803	Kafrelsheikh University	Phase 4
Completed	Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidi NCT03753113	Farid Masoud	Phase 3
Completed	A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alop NCT03742518	Biosplice Therapeutics, Inc.	Phase 2 / Phase 3
Completed	Androgenetic Alopecia and the JAK-STAT Pathway NCT03694067	Cairo University	—
Completed	The Effect of Platelet Rich Plasma on Non-scarring Alopecia NCT03689452	Icahn School of Medicine at Mount Sinai	N/A
Completed	A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss NCT04450589	Arbor Life Labs	N/A
Completed	A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss NCT04450602	Arbor Life Labs	N/A
Completed	A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution NCT03495817	Aclaris Therapeutics, Inc.	Phase 2
Completed	Optimizing Parameters for Long-pulsed Nd:YAG Laser for Reducing Hair Shaft Diameter NCT03394235	Institute of Dermatology, Thailand	N/A
Unknown	Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction NCT03388840	Assiut University	Phase 4
Completed	The Utility of Platelet Rich Plasma in Hair Loss NCT03376581	University of California, Irvine	EARLY_Phase 1
Completed	Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment NCT02591355	Regen Lab SA	N/A
Completed	Modulated Light Therapy in Participants With Pattern Hair Loss NCT04019795	PhotonMD, Inc	N/A
Unknown	Comparing Different Platelet Rich Plasma (PRP) Treatment Regimens for Management of Androgenic Alopecia NCT02999737	Skin Care and Laser Physicians of Beverly Hills	Phase 4
Completed	Point-of-Care Adipose-derived Cells for Hair Growth NCT02729415	University of Florida	N/A
Completed	Adipose-derived SVF for Treatment of Alopecia NCT02626780	GID BIO, Inc.	N/A
Completed	Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic NCT02848300	Allergan	Phase 1
Withdrawn	Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxi NCT02486848	Maja Kovacevic, MD	N/A
Completed	Photosensitization Study in Androgenetic Alopecia NCT02791243	Polichem S.A.	Phase 1
Unknown	Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO NCT02528552	Theradome, Inc.	Phase 2
Completed	A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biop NCT02503137	Biosplice Therapeutics, Inc.	Phase 2
Terminated	PAI-1 Expression in Non-scarring Hair Loss NCT02548689	Northwestern University	—
Completed	DUS on the Prescribing Indications for CPA/EE in 5 European Countries NCT02494297	Center for Epidemiology and Health Research, Germany	—
Completed	A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenet NCT02275351	Biosplice Therapeutics, Inc.	Phase 2
Completed	A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle So NCT02279823	Intrepid Therapeutics, Inc.	Phase 2
Completed	Minoxidil Response Testing in Males With Androgenetic Alopecia NCT02198261	Applied Biology, Inc.	—
Completed	Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss NCT02150187	Family Marketing	Phase 2
Unknown	Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia NCT02154503	Vancouver General Hospital	Phase 1
Unknown	Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia NCT02074943	Vancouver General Hospital	N/A
Completed	A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy NCT01967277	Capillus, LLC	N/A
Unknown	Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia NCT02393040	Universitat Internacional de Catalunya	N/A
Completed	Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application NCT02280603	Dong-A ST Co., Ltd.	Phase 1 / Phase 2
Withdrawn	Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia NCT01885676	Biotechnology Institute IMASD	N/A
Unknown	Split Wound Comparison of Trichophytic Closure Techniques for Donor Site in Hair Transplantation NCT01655602	Siriraj Hospital	Phase 1
Unknown	24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female B NCT01686295	Freedom Laser Therapy, Inc.	N/A
Completed	A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Baldi NCT01669746	Aderans Research Institute	Phase 2
Unknown	A Study to Determine the Safety and Efficacy of Autologous Human Platelet Lysate for Treatment of Androgenetic NCT01643629	Kasiak Research Pvt. Ltd.	Phase 1 / Phase 2
Unknown	Study To Determine Safety & Efficacy Of Autologous Human Platelet Lysate in Androgenetic Alopecia After Hair T NCT01644422	Kasiak Research Pvt. Ltd.	Phase 1 / Phase 2
Unknown	Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia NCT01501617	Histogen	Phase 1 / Phase 2
Completed	Treatment of Androgenetic Alopecia in Males and Females NCT01437163	Apira Science, Inc.	N/A
Completed	The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss NCT01548066	Seoul National University Hospital	Phase 2
Completed	A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Sca NCT01451190	Aderans Research Institute	Phase 2
Completed	Microarray Analysis of Scalp Biopsies After Minoxidil Treatment NCT01309191	University Hospitals Cleveland Medical Center	N/A
Completed	Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair NCT01391156	Mae Fah Luang University Hospital	Phase 3
Completed	Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study NCT05129800	Faculty Hospital Kralovske Vinohrady	—
Completed	A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Sca NCT01451151	Aderans Research Institute	Phase 2
Completed	Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia NCT01286649	TrichoScience Innovations, Inc.	Phase 1 / Phase 2
Completed	Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia NCT01319370	Natalie GARCIA BARTELS	Phase 2
Completed	A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of NCT01451138	Aderans Research Institute	Phase 2
Completed	Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia NCT01231607	GlaxoSmithKline	Phase 3
Unknown	Pharmacogenomic Study of Androgenetic Alopecia NCT01227031	Taipei Medical University WanFang Hospital	—
Completed	Clinical Trial in Females for Female Pattern Hair Loss NCT01226459	Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.	Phase 3
Completed	A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of NCT01451125	Aderans Research Institute	Phase 2
Completed	A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of NCT01451177	Aderans Research Institute	Phase 2
Completed	Treatment of Androgenetic Alopecia in Females, 12 Beam NCT01016964	Lexington International, LLC	N/A
Completed	Topical Bimatoprost Effect on Androgen Dependent Hair Follicles NCT02170662	Duke University	Phase 2
Completed	Treatment of Androgenetic Alopecia in Females, 9 Beam NCT00981461	Lexington International, LLC	N/A
Completed	Treatment of Androgenetic Alopecia in Males NCT00947505	Lexington International, LLC	N/A
Completed	A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of NCT01451112	Aderans Research Institute	Phase 2
Completed	A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of NCT01451047	Aderans Research Institute	Phase 2
Completed	Treatment of Androgenic Alopecia in Males NCT00947219	Lexington International, LLC	N/A
Completed	Computer-Assisted Versus Manual Hair Harvest Comparative Study NCT00926211	Restoration Robotics, Inc.	N/A
Completed	A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With NCT01451099	Aderans Research Institute	Phase 2
Completed	A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of NCT01451073	Aderans Research Institute	Phase 2
Completed	Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic NCT01052870	HairDx, LLC	Phase 1
Completed	A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of NCT01451021	Aderans Research Institute	Phase 2
Completed	Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia NCT00958750	Charite University, Berlin, Germany	Phase 3
Unknown	Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss NCT00471510	Neosil, Inc.	Phase 2
Completed	Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss NCT00418730	Neosil, Inc.	Phase 2
Completed	A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern NCT00151515	Johnson & Johnson Consumer and Personal Products Worldwide	Phase 3
Completed	Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females NCT01701271	Mexis George	N/A
Completed	Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111) NCT00396175	Organon and Co	Phase 3
Completed	A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Trea NCT02067260	Spencer Forrest, Inc.	N/A